Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|20|29|4760-4765
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.20, Iss.29, 2014-09, pp. : 4760-4765
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sjogren’s syndrome: evolving therapies
By Fox Robert I
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. :
Access to resources
Recommend
Sjogren’s syndrome: models of pathogenesis and treatment targets
By Derk Chris T
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. :
Anti-CD20 Antibody in Primary Sjogren’s Syndrome Management
Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. :
Pharmacological Aspects of Neuro-Immune Interactions
Current Pharmaceutical Design, Vol. 24, Iss. 1, 2018-03 ,pp. :
Primary Sjogren's Syndrome and the Type I Interferon System
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :